The Treatment Continuity Act of 2025 amends federal law to expand treatment options for substance use disorders and serious mental illness by authorizing the Secretary of Health and Human Services to fund programs that provide long-acting injectable medications approved by the FDA, along with lab testing, counseling, and provider training. The legislation affects healthcare providers, treatment facilities, and patients struggling with addiction and mental health conditions by increasing access to these medications and supportive services. The bill requires the Secretary to submit annual reports to Congress starting one year after enactment documenting program outcomes and patient progress toward treatment goals. No specific funding amounts are outlined in the legislation; instead, it grants authority to distribute existing federal grants under the Public Health Service Act. The amendments apply to all grants distributed under this program after the law is enacted.
Take Action
Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.